Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 26, 2006
Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposityLuc F Van GaalSeminars in Vascular Medicine|June 22, 2005
Visceral fat as a determinant of fibrinolysis and hemostasisIlse Mertens, Luc F Van GaalCurrent Obesity Reports|January 5, 2021
Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an UpdateAnn A Verhaegen, Luc F Van GaalThe Lancet. Diabetes & Endocrinology|September 19, 2017
Progress and challenges in anti-obesity pharmacotherapyDaniel H Bessesen, Luc F Van GaalObesity (Silver Spring, Md.)|February 28, 2009
Low fasting triglycerides: hallmark of the healthy large hip?Johannes B Ruige, Luc F Van GaalThe Lancet. Diabetes & Endocrinology|April 16, 2014
Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetesAndré J Scheen, Luc F Van GaalExpert Review of Endocrinology & Metabolism|February 14, 2019
Efficacy and safety of exenatide once weekly: an overview of the DURATION trialsChristophe Em De Block, Luc F Van GaalEuropean Endocrinology|June 21, 2018
Can Bariatric Surgery be Considered Standard Therapy to Treat Type 2 Diabetes?Karen Meyvis, Christophe De Block, Luc F Van GaalCurrent Opinion in Endocrinology, Diabetes, and Obesity|August 17, 2012
Bariatric surgery to treat type 2 diabetes: what is the recent evidence?Luc F Van Gaal, Christophe E M De BlockRevue Medicale Suisse|September 26, 2008
[CB1 receptor inhibition and glucose metabolism: role of rimonabant in type 2 diabetes]André J Scheen, Nicolas Paquot, Luc F Van GaalPageof 9